Michael T. Lewis

Baylor College of Medicine — United States

Medicine · Health Sciences

55h-index13.6kcitations530works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(142), Cancer Genomics and Diagnostics(120), Radiomics and Machine Learning in Medical Imaging(90), AI in cancer detection(81), Epigenetics and DNA Methylation(46)

Publications527 total

eIF3d and eIF3e mediate selective translational control of hypoxia that can be inhibited by small molecules
Cell Reports·2025· 2 citedOpen Access
Supplementary Data from Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer
2025Open Access
Table S3 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025Open Access
Figure S4 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025Open Access
Figure S3 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025Open Access
Table S2 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025Open Access
Figure S1 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025Open Access
Figure S5 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025Open Access
Figure S6 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025Open Access
Table S1 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025Open Access
Table S4 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025Open Access
Figure S2 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025Open Access
Data from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025Open Access
Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
Cancer Discovery·2025· 1 cited
Abstract PS4-02: Patient-derived Xenografts (PDX) Allow Deconvolution of Combination Chemotherapy Response
Clinical Cancer Research·2025
Abstract P2-02-22: BCM PDX Insights Portal: An Intuitive Web-based Tool for Patient-Derived Xenograft Collection Management to Facilitate Pre-clinical Studies in Breast Cancer
Clinical Cancer Research·2025
Abstract P3-04-16: Tumor Tissue Slices from Breast Cancer Patient Derived Xenografts as an Ex Vivo Method for Treatment Response
Clinical Cancer Research·2025
eIF3d and eIF3e mediate selective translational control of hypoxia that can be inhibited by novel small molecules
2025Open Access
Supplementary Data from Lineage Tracing and Single-Cell RNA Sequencing Reveal a Common Transcriptional State in Breast Cancer Tumor–Initiating Cells Characterized by IFN/STAT1 Activity
2025Open Access
Supplementary Data from Lineage Tracing and Single-Cell RNA Sequencing Reveal a Common Transcriptional State in Breast Cancer Tumor–Initiating Cells Characterized by IFN/STAT1 Activity
2025Open Access
page 1 of 27Next →

Frequent Co-authors

Lacey E. Dobrolecki(19), Susan G. Hilsenbeck(13), Jenny C. Chang(9), Melissa D. Landis(7), Jeffrey M. Rosen(6), Chad J. Creighton(6), Helen Wong(6), Matthew J. Ellis(6), Xiaomei Zhang(5), Anna Tsimelzon(5), Mothaffar F. Rimawi(5), C. Kent Osborne(4), Gary C. Chamness(4), Alana L. Welm(4), Thomas F. Westbrook(4), Ricardo Moraes(4), Carolina Gutiérrez(3), Anne C. Pavlick(3), Angel Rodriguez(3), Ik Sun Kim(3)